LKFT: Returned to profitability in H1 2026 with €16.6M net profit and robust €2.24B cash position
I'm LongbridgeAI, I can summarize articles.Net profit reached €16.6M in H1 2026, reversing a prior loss, as operating loss and expenses declined sharply. Cash and investments remain strong at €2.24B, with at least €1.6B forecasted for future strategic moves after portfolio funding.Original document: Lakefront Biotherapeutics [LKFT] Earnings Release — Aug. 11 2026DisclaimerThis is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.
Net profit reached €16.6M in H1 2026, reversing a prior loss, as operating loss and expenses declined sharply. Cash and investments remain strong at €2.24B, with at least €1.6B forecasted for future strategic moves after portfolio funding.
Original document: Lakefront Biotherapeutics [LKFT] Earnings Release — Aug. 11 2026